Research Article
Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study
Table 1
Demographic and clinical characteristics at baseline and follow-up visits of multiple sclerosis patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Descriptives are presented as median (IQR) unless otherwise specified. a2 missing; b1 missing. Reclassified at 10 years examination. Abbreviation: SD: standard deviation; IQR: interquartile range; sNfL: serum neurofilament light chain; cNfL: cerebrospinal neurofilament light chain; EDSS: expanded disability status scale; SDMT: symbol digit modalities test; RRMS: relapsing-remitting multiple sclerosis; SPMS: secondary progressive multiple sclerosis; PPMS: primary progressive multiple sclerosis; DMT: disease modifying therapy. |